Analytical performance of a new immunoturbidimetric D‐dimer assay and comparison with available assays - Archive ouverte HAL Access content directly
Journal Articles Research and Practice in Thrombosis and Haemostasis Year : 2022

Analytical performance of a new immunoturbidimetric D‐dimer assay and comparison with available assays

(1) , (1) , (1) , (2) , (1) , (1, 3)
1
2
3

Abstract

Background: The routine D-dimer quantification to exclude venous thromboembolism has led to the development of many assays, the usefulness of which depends on their reliability and performance. Objective: We evaluated the analytical performances of the immunoturbidimetric Yumizen G DDi 2 assay (HORIBA Medical, Montpellier, France) performed on the Yumizen G800 analyzer and compared it with other available D-dimer assays. Methods: Within-run and between-run imprecision were evaluated using low- and high-level quality-control plasma samples. Interference due to hemolysis, icterus, lipemia, rheumatoid factor (RF), or heterophilic antibodies (human antimouse antibodies [HAMAs]) was evaluated by spiking plasma samples with hemolysate, bilirubin, Intralipid, RF, or HAMAs. The measurements obtained with the different D-dimer assays were compared using Passing-Bablok regression analysis and Bland-Altman plot method, using fresh citrated plasma samples collected from 66 consecutive routine patients with a wide range of D-dimer concentrations. Results: Within- and between-run variation coefficients for the Yumizen G DDi 2 assay ranged from 1.7% to 5.8% and from 2.8% to 5.5%, respectively. Hemolysis and icterus did not have any effect up to 10 g/L hemoglobin and 300 mg/L bilirubin. Lipemia seemed to generate an underestimation of D-dimer concentration when the Intralipid concentration was >5 g/L. RF and HAMAs did not have any effect. The Passing-Bablok and Bland-Altman analyses showed small differences with other available D-dimer assays, which were more pronounced with increasing values. Conclusions: Its analytical performances and main technical features indicate that the new Yumizen G DDi 2 assay is suitable for the rapid quantification of D-dimer in clinical hemostasis laboratories.
Fichier principal
Vignette du fichier
2022_Talon_Res_Practice Thromb_Haemos.pdf (1 Mo) Télécharger le fichier
Origin : Publisher files allowed on an open archive

Dates and versions

hal-03776224 , version 1 (13-09-2022)

Licence

Attribution - CC BY 4.0

Identifiers

Cite

Laurie Talon, Virginie Fourneyron, Alexandre Trapani, Bruno Pereira, Thomas Sinègre, et al.. Analytical performance of a new immunoturbidimetric D‐dimer assay and comparison with available assays. Research and Practice in Thrombosis and Haemostasis, 2022, 6 (1), ⟨10.1002/rth2.12660⟩. ⟨hal-03776224⟩
34 View
29 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More